DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name ▲ | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1306459 | Primary malignant neoplasm | UGGT1 | 56886 | UDP-glucose glycoprotein glucosyltransferase 1 | Q9NYU2 |
C1306459 | Primary malignant neoplasm | ST3GAL4 | 6484 | ST3 beta-galactoside alpha-2,3-sialyltransferase 4 | Q11206 |
C1306459 | Primary malignant neoplasm | ST8SIA4 | 7903 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 | Q92187 |
C1306459 | Primary malignant neoplasm | UGCG | 7357 | UDP-glucose ceramide glucosyltransferase | Q16739 |
C1306459 | Primary malignant neoplasm | UGT8 | 7368 | UDP glycosyltransferase 8 | Q16880 |
C1306459 | Primary malignant neoplasm | ST3GAL3 | 6487 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | Q11203 |
C1306459 | Primary malignant neoplasm | OGT | 8473 | O-linked N-acetylglucosamine (GlcNAc) transferase | O15294 |
C1306459 | Primary malignant neoplasm | GALNT14 | 79623 | polypeptide N-acetylgalactosaminyltransferase 14 | Q96FL9 |
C1306459 | Primary malignant neoplasm | ST8SIA2 | 8128 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | Q92186 |
C1306459 | Primary malignant neoplasm | ALG2 | 85365 | ALG2 alpha-1,3/1,6-mannosyltransferase | Q9H553 |
C1306459 | Primary malignant neoplasm | CHPF | 79586 | chondroitin polymerizing factor | Q8IZ52 |
C1306459 | Primary malignant neoplasm | GPAA1 | 8733 | glycosylphosphatidylinositol anchor attachment 1 | O43292 |
C1306459 | Primary malignant neoplasm | ST6GALNAC5 | 81849 | ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 | Q9BVH7 |
C1306459 | Primary malignant neoplasm | GALNT12 | 79695 | polypeptide N-acetylgalactosaminyltransferase 12 | Q8IXK2 |
C1306459 | Primary malignant neoplasm | B4GALT3 | 8703 | beta-1,4-galactosyltransferase 3 | O60512 |
C1306459 | Primary malignant neoplasm | PIGS | 94005 | phosphatidylinositol glycan anchor biosynthesis class S | Q96S52 |
C1306459 | Primary malignant neoplasm | B4GALT5 | 9334 | beta-1,4-galactosyltransferase 5 | O43286 |
C1306459 | Primary malignant neoplasm | CHST3 | 9469 | carbohydrate sulfotransferase 3 | Q7LGC8 |
C1306459 | Primary malignant neoplasm | GAL3ST1 | 9514 | galactose-3-O-sulfotransferase 1 | Q99999 |
C1306459 | Primary malignant neoplasm | HS3ST2 | 9956 | heparan sulfate-glucosamine 3-sulfotransferase 2 | Q9Y278 |
C1306459 | Primary malignant neoplasm | GCNT3 | 9245 | glucosaminyl (N-acetyl) transferase 3, mucin type | O95395 |
C1306459 | Primary malignant neoplasm | HS3ST1 | 9957 | heparan sulfate-glucosamine 3-sulfotransferase 1 | O14792 |
C1306459 | Primary malignant neoplasm | SLC26A2 | 1836 | solute carrier family 26 member 2 | P50443 |
C1306459 | Primary malignant neoplasm | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C1306459 | Primary malignant neoplasm | GALNS | 2588 | galactosamine (N-acetyl)-6-sulfatase | P34059 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024